Here’s the difference between adaptive and innate immunity.
Category: pharma
Highmark Completes Deal With HealthNow To Become Fourth-Largest Blue Cross Plan
Blue Cross and Blue Shield plan Highmark said it has completed its “affiliation” agreement with HealthNow New York to become nation’s fourth-largest Blues plan.
As Johnson & Johnson’s One-Shot Covid-19 Vaccine Joins The Fight, Hesitancy Could Subside
The addition of Johnson & Johnson’s single-dose vaccine in the U. S. could spur more Americans to get immunized against Covid-19 and further reduce vaccine hesitancy, polls indicate.
How Health Insurance Became America’s Biggest Hustle
There’s a brilliant hustle happening all over the country, drawing in more than half of all U. S. workers—and this one is perfectly legal. The game is called high-deductible health insurance.
Surgeon Joined His Zoom Court Trial During An Operation, Here Is The Video
The Sacramento Superior Court Commissioner called it inappropriate and decided to have the trial rescheduled.
Need For Human Connection Creates Unexpected, Positive Use Of Clubhouse
What started out as a concept for a four-hour event in response to bullying and depression on Clubhouse turned into a four-day Mental Health Summit. On Clubhouse. But it wasn’t crafted by a marketing team or influencer. Instead, it grew organically tha…
105-Year-Old Recovered From Covid-19, Her Tip? Eating Gin-Soaked Raisins
A New jersey woman found out she tested positive on her 105th birthday, one day after she got her second dose of the Pfizer/BioNTech Covid-19 coronavirus vaccine.
Discount Insulin Will Cost You
Discount insulin may not benefit you. So who does it benefit? Pharmaceutical companies.
Cigna’s Evernorth To Buy Telehealth Provider MDLive
Cigna’s Evernorth healthcare services business will buy MDLive, a fast-growing provider of telehealth services that have taken off during the Covid-19 pandemic.
Pfizer Should Be Wary About Covid-19 Vaccine Price Hikes
In early July of 2020, Elisabeth Rosenthal published an op-ed in the New York Times warning about the biopharmaceutical industry trying to profit outrageously from a successful Covid-19 vaccine.
